WDB coco CoTSE:7079 -0.47%78 FCF Margin % is 11.11% as of Mar. 2026, which is 24% below its 10-year median of 14.65. GuruFocus rates TSE:7079 with a GF Score™ of 78/100 and a GF Value™ of 円3,452.59 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 669 Healthcare Providers & Services companies, WDB coco Co ranks better than 75.34% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. WDB coco Co's Free Cash Flow for the
six
months ended in Mar. 2026 was 円267 Mil. WDB coco Co's Revenue for the
six
months ended in Mar. 2026 was 円2,401 Mil. Therefore, WDB coco Co's FCF Margin % for the quarter that ended in Mar. 2026 was 11.11%.
The historical rank and industry rank for WDB coco Co's FCF Margin % or its related term are showing as below:
TSE:7079'
s FCF Margin % Range Over the Past 10 Years
Min: 10.31 Med: 14.65 Max: 20.44
Current: 10.82
During the past 9 years, the highest FCF Margin % of WDB coco Co was 20.44%. The lowest was 10.31%. And the median was 14.65%.
TSE:7079's FCF Margin % is ranked better than 75.34% of 669
companies
in the Healthcare Providers & Services industry
Industry Median: 3.39
vs TSE:7079: 10.82
WDB coco Co FCF Margin % Related Terms
WDB coco Co FCF Margin % Historical Data
* Premium members only.
The historical data trend for WDB coco Co's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7079 vs VEEV, BTSG, TEM: FCF Margin % Comparison
For the Health Information Services subindustry, WDB coco Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
WDB coco Co FCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, WDB coco Co's FCF Margin % distribution charts can be found below:
* The bar in red indicates where WDB coco Co's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WDB coco Co (TSE:7079) has a FCF Margin % of 11.11% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on WDB coco Co and its competitors. This is 24% below median its historical median of 14.65. Over the past decade, WDB coco Co's FCF Margin % has ranged from 10.31 to 20.44. According to the industry distribution chart, WDB coco Co ranks #165 out of 669 companies in the Healthcare Providers & Services industry, placing it in the top 24.7%.
Is WDB coco Co's FCF Margin % too high?
WDB coco Co's current FCF Margin % of 11.11% is 24% below median its 10-year median of 14.65. Over the past 10 years, this metric has ranged from a low of 10.31 to a high of 20.44. The Healthcare Providers & Services industry median FCF Margin % is 3.39. WDB coco Co's value of 11.11% is 227.7% above this industry median. Based on the distribution chart, WDB coco Co ranks #165 out of 669 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, WDB coco Co has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does WDB coco Co's FCF Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, WDB coco Co ranks #165 out of 669 companies for FCF Margin %. This places WDB coco Co in the top 25% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 3.39. WDB coco Co's value of 11.11% is 227.7% above this benchmark. Historically, WDB coco Co's own FCF Margin % has ranged from 10.31 to 20.44 over the past decade. While the company's 10-year median is 14.65 vs. the industry median of 3.39, WDB coco Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.39, based on 669 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. WDB coco Co's current FCF Margin % of 11.11% is 227.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on WDB coco Co and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. WDB coco Co's current FCF Margin % is 11.11%, which is 24% below median its own 10-year median of 14.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is WDB coco Co stock overvalued right now?
Based on GuruFocus' analysis, WDB coco Co (TSE:7079) is currently considered Modestly Undervalued. The stock's GF Value™ is 円3,452.59, compared to a current price of 円2,529.00 — trading 26.8% below its estimated fair value. The current FCF Margin % is 11.11%, which is 24% below median its 10-year median of 14.65 and 227.7% above the Healthcare Providers & Services industry median of 3.39. WDB coco Co's overall GF Score™ is 78/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For WDB coco Co (TSE:7079), the current FCF Margin % is 11.11% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is WDB coco Co (TSE:7079) Overvalued in 2026?
Based on GuruFocus' analysis, WDB coco Co stock appears to be undervalued.
The current stock price of 円2,529.00 is trading 26.8% below its estimated GF Value™ of 円3,452.59.
GuruFocus considers WDB coco Co to be Modestly Undervalued.
Key valuation signals for TSE:7079:
FCF Margin %: 11.11% (24% below median its 10-year median of 14.65)
GF Value™: 円3,452.59 vs. price of 円2,529.00 (26.8% below fair value)
Industry Position: 227.7% above the Healthcare Providers & Services median (#165 of 669)
No single metric tells the full story. See the TSE:7079 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
WDB coco Co Ltd is a provider of safety information management for the development of pharmaceuticals and medical devices. Its services include business related to safety information management, preparation of materials related to regulatory application, QC-related work, PMS facility contract support related work, clinical research support/monitoring, and temporary staffing. The company provides Contract Research Organization services for all new drug developments, such as monitoring, safety information, data management, and statistical analysis. It provides support for the development of generic drugs, such as bioequivalence studies and biosimilars, clinical research, and physician-led clinical trials.
78GF Score
Get the complete analysis for TSE:7079
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7079 has been successfully added to your 
